EUVIMEDEUVIMED entdecken
Fallbericht

Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis

Kelly K Barry, Marilyn G Liang, Daniel M Balkin, Siddharth Srivastava, Alanna J Church iD, Whitney Eng

Pediatric Dermatology · 2024-01 · 41 (1) · 76-79

DOI: 10.1111/pde.15353 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, online erschienen am 24.07.2023. Verfasst von Kelly K Barry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tufts University School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Neurocutaneous Syndromes, Eye Diseases, Lipomatosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: NIH National Institute of Neurological Disorders and Stroke, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Encephalocraniocutaneous lipomatosis (ECCL) is a rare neurocutaneous disorder caused by somatic FGFR1 and KRAS variants. It shares significant phenotypic overlap with several closely related disorders caused by mutations in the RAS‐MAPK pathway (mosaic RASopathies). We report a diagnostically challenging case of ECCL in which next‐generation sequencing of affected tissue identified a pathologic FGFR1 p.K656E variant, thereby establishing a molecular diagnosis. Patients with FGFR1 ‐associated ECCL carry a risk of developing malignant brain tumors; thus, genetic testing of patients with suspected ECCL has important management implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurocutaneous SyndromesEye DiseasesLipomatosisHumansHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

ECCLFGFR1KRASRASopathyencephalocraniocutaneous lipomatosislinear nevus sebaceous syndromemosaicoculoectodermal syndrome

Autor:innen und Institutionen

  • Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Department of Dermatology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Plastic & Oral Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Alanna J Church

Förderung

  • NIH National Institute of Neurological Disorders and Stroke
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Barry, K. K., Liang, M. G., Balkin, D. M., Srivastava, S., Church, A. J., & Eng, W. (2024). Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis. Pediatric Dermatology, 41(1), 76-79. https://doi.org/10.1111/pde.15353

Vancouver

Barry KK, Liang MG, Balkin DM, Srivastava S, Church AJ, Eng W. Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis. Pediatric Dermatology. 2024;41(1):76-79. doi:10.1111/pde.15353

BibTeX
@article{Barry2024,
  author = {Barry, Kelly K and Liang, Marilyn G and Balkin, Daniel M and Srivastava, Siddharth and Church, Alanna J and Eng, Whitney},
  title = {Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis},
  journal = {Pediatric Dermatology},
  year = {2024},
  volume = {41},
  number = {1},
  pages = {76--79},
  doi = {10.1111/pde.15353}
}
Kostenlos starten →